Antinuclear antibodies in non-systemic autoimmune rheumatic disease dermatological conditions
Antinuclear antibodies (ANA) indirect immunofluorescence assay (IFA) is the first line immunological investigation, mainly for systemic autoimmune rheumatic disease (SARD). However, ANA is also being requested in certain dermatological conditions particularly in those with immune dysregulation as un...
Saved in:
Main Authors: | Mahayidin, Hasni, Bakrin, Ikmal Hisyam |
---|---|
Format: | Article |
Published: |
Universiti Putra Malaysia
2021
|
Online Access: | http://psasir.upm.edu.my/id/eprint/95924/ https://medic.upm.edu.my/jurnal_kami/volume_17_2021/mjmhs_vol17_supp_10_december_2021-64369 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Frequency of antinuclear antibodies in normal healthy population in Pakistan
by: Atif, Amin Baig, et al.
Published: (2017) -
Quantification of Antinuclear Antibodies (IgG) Existence in General Population of Pakistan
by: Atif Amin, Baig, et al.
Published: (2018) -
Pediatric antinuclear antibody negative full-house nephropathy: A clinical conundrum
by: Abu Bakar, Karmila, et al.
Published: (2022) -
Biologics in rheumatic diseases
by: Abdullah, Hilmi
Published: (2017) -
The prevalence and associated factors of clinical and subclinical rheumatic heart disease among rheumatic heart disease children admitted in HUSM
by: Zainol, Ahmad Rodzi
Published: (2015)